{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:00:15Z","timestamp":1787922015912,"version":"build-2784847793"},"reference-count":135,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Immunotherapies are recently emerged as a new strategy in treating various kinds of cancers which are insensitive to standard therapies, while the clinical application of immunotherapy is largely compromised by the low efficiency and serious side effects. Gut microbiota has been shown critical for the development of different cancer types, and the potential of gut microbiota manipulation through direct implantation or antibiotic-based depletion in regulating the overall efficacy of cancer immunotherapies has also been evaluated. However, the role of dietary supplementations, especially fungal products, in gut microbiota regulation and the enhancement of cancer immunotherapy remains elusive. In the present review, we comprehensively illustrated the limitations of current cancer immunotherapies, the biological functions as well as underlying mechanisms of gut microbiota manipulation in regulating cancer immunotherapies, and the benefits of dietary fungal supplementation in promoting cancer immunotherapies through gut microbiota modulation.<\/jats:p>","DOI":"10.3389\/fonc.2023.1038710","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T17:35:57Z","timestamp":1678296957000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Dietary fungi in cancer immunotherapy: From the perspective of gut microbiota"],"prefix":"10.3389","volume":"13","author":[{"given":"Yibing","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingka","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: From T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6711","article-title":"Car T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1600-065X.1999.tb01331.x","article-title":"Human tumor antigens for cancer vaccine development","volume":"170","author":"Wang","year":"1999","journal-title":"Immunol Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13027","article-title":"Oncolytic virus therapy: A new era of cancer treatment at dawn","volume":"107","author":"Fukuhara","year":"2016","journal-title":"Cancer Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658753","article-title":"Engineered tcr-T cell immunotherapy in anticancer precision medicine: Pros and cons","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00409","article-title":"Nkt cells as an ideal anti-tumor immunotherapeutic","volume":"4","author":"Fujii","year":"2013","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"109821","DOI":"10.1016\/j.biopha.2020.109821","article-title":"Cancer immunotherapy: Pros, cons and beyond","volume":"124","author":"Tan","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3322\/caac.21596","article-title":"A review of cancer immunotherapy toxicity","volume":"70","author":"Kennedy","year":"2020","journal-title":"CA: A Cancer J Clin"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: Epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.e14151","article-title":"Incidence and clinical pattern of immune related adverse effects (Irae) due to immune checkpoint inhibitors (Ici)","volume":"37","author":"Thapa","year":"2019","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.611366","article-title":"Characteristics and risk factors of cytokine release syndrome in chimeric antigen receptor T cell treatment","volume":"12","author":"Yan","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1605-5","article-title":"Microbiota and metabolic diseases","volume":"61","author":"Pascale","year":"2018","journal-title":"Endocrine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.616883","article-title":"The contribution of gut microbiota-brain axis in the development of brain disorders","volume":"15","author":"Maiuolo","year":"2021","journal-title":"Front Neurosci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1136\/gutjnl-2020-321153","article-title":"The role of gut microbiota in cancer treatment: Friend or foe","volume":"69","author":"Cheng","year":"2020","journal-title":"Gut"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2021.01.010","article-title":"Gut microbiota in cancer immune response and immunotherapy","volume":"7","author":"Zhou","year":"2021","journal-title":"Trends Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.3390\/nu11122862","article-title":"Effect of diet on the gut microbiota: Rethinking intervention duration","volume":"11","author":"Leeming","year":"2019","journal-title":"Nutrients"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.02.014","article-title":"Dietary modulation of the gut microbiome as an immunoregulatory intervention","volume":"40","author":"Matson","year":"2022","journal-title":"Cancer Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1039\/d0fo00255k","article-title":"Bilberry anthocyanin extracts enhance anti-Pd-L1 efficiency by modulating gut microbiota","volume":"11","author":"Wang","year":"2020","journal-title":"Food Funct"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7271509","DOI":"10.1155\/2018\/7271509","article-title":"Potential of mushroom compounds as immunomodulators in cancer immunotherapy: A review","volume":"2018","author":"Ayeka","year":"2018","journal-title":"Evidence-Based Complementary Altern Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","article-title":"Cancer immunoediting from immune surveillance to immune escape","volume":"121","author":"Kim","year":"2007","journal-title":"Immunology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2018.08.005","article-title":"Immune checkpoint molecules, personalized immunotherapy, and autoimmune diabetes","volume":"24","author":"Orabona","year":"2018","journal-title":"Trends Mol Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1849","article-title":"Reversing T-cell dysfunction and exhaustion in cancer","volume":"22","author":"Zarour","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13046-019-1259-z","article-title":"Combination of ctla-4 and pd-1 blockers for treatment of cancer","volume":"38","author":"Rotte","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716078","article-title":"Neoadjuvant pd-1 blockade in resectable lung cancer","volume":"378","author":"Forde","year":"2018","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1086-y","article-title":"Neoadjuvant pd-L1 plus ctla-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma","volume":"26","author":"Gao","year":"2020","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"Ctla-4 and pd-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"110331","DOI":"10.1016\/j.celrep.2022.110331","article-title":"Pd-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes","volume":"38","author":"Nagasaki","year":"2022","journal-title":"Cell Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-2053-4","article-title":"Ctla-4\/Cd80 pathway regulates T cell infiltration into pancreatic cancer","volume":"66","author":"Bengsch","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.4110\/in.2022.22.e2","article-title":"Immune checkpoint inhibitors in 10 years: Contribution of basic research and clinical application in cancer immunotherapy","volume":"22","author":"Lee","year":"2022","journal-title":"Immune Netw"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s12254-021-00699-0","article-title":"Novel immune checkpoints beyond pd-1 in advanced melanoma","volume":"14","author":"Zila","year":"2021","journal-title":"memo - Magazine Eur Med Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2020.11","article-title":"A review of mechanisms of resistance to immune checkpoint inhibitors and potential strategies for therapy","volume":"3","author":"Fujiwara","year":"2020","journal-title":"Cancer Drug Resistance"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1758835920937612","DOI":"10.1177\/1758835920937612","article-title":"Efficacy of pd-1\/Pd-L1 blockade monotherapy in clinical trials","volume":"12","author":"Zhao","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s40425-019-0805-8","article-title":"Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors","volume":"7","author":"Das","year":"2019","journal-title":"J ImmunoTher Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.11.016","article-title":"Immune-related adverse events with immune checkpoint blockade: A comprehensive review","volume":"54","author":"Michot","year":"2016","journal-title":"Eur J Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.03.132","article-title":"Immune checkpoint inhibitor-related dermatologic adverse events","volume":"83","author":"Geisler","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01547","article-title":"Checkpoint blockade toxicity and immune homeostasis in the gastrointestinal tract","volume":"8","author":"Dougan","year":"2017","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2218-6751.2015.06.06","article-title":"Immune checkpoint inhibitors in clinical practice: Update on management of immune-related toxicities","volume":"4","author":"Villadolid","year":"2015","journal-title":"Trans Lung Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41573-021-00259-5","article-title":"Immune-related toxicities of checkpoint inhibitors: Mechanisms and mitigation strategies","volume":"21","author":"Sullivan","year":"2022","journal-title":"Nat Rev Drug Discovery"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01623-z","article-title":"T Cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma","volume":"28","author":"Lozano","year":"2022","journal-title":"Nat Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0238-9","article-title":"Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis","volume":"24","author":"Wang","year":"2018","journal-title":"Nat Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01406-6","article-title":"Gut microbiota signatures are associated with toxicity to combined ctla-4 and pd-1 blockade","volume":"27","author":"Andrews","year":"2021","journal-title":"Nat Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-Pd-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of pd-1-Based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","first-page":"10391","DOI":"10.1038\/ncomms10391","article-title":"Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-Blockade-Induced colitis","volume":"7","author":"Dubin","year":"2016","journal-title":"Nat Commun"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3390\/pharmaceutics14061243","article-title":"Bispecific antibodies in cancer immunotherapy: A novel response to an old question","volume":"14","author":"Ord\u00f3\u00f1ez-Reyes","year":"2022","journal-title":"Pharmaceutics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13045-021-01045-x","article-title":"The construction, expression, and enhanced anti-tumor activity of Ym101: A bispecific antibody simultaneously targeting tgf-\u03b2 and pd-L1","volume":"14","author":"Yi","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005543","article-title":"Anti-Tgf-\u03b2\/Pd-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer","volume":"10","author":"Yi","year":"2022","journal-title":"J ImmunoTher Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1426519","article-title":"M7824, a novel bifunctional anti-Pd-L1\/Tgf\u03b2 trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine","volume":"7","author":"Knudson","year":"2018","journal-title":"Oncoimmunology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700233","article-title":"Downregulation of major histocompatibility complex antigens in invading glioma cells: Stealth invasion of the brain","volume":"85","author":"Zagzag","year":"2005","journal-title":"Lab Invest"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0548","article-title":"The basic principles of chimeric antigen receptor design","volume":"3","author":"Sadelain","year":"2013","journal-title":"Cancer Discovery"},{"key":"B57","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/0092-8674(91)90314-O","article-title":"The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways","volume":"64","author":"Irving","year":"1991","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13239","article-title":"Clinical development of anti-Cd19 chimeric antigen receptor T-cell therapy for b-cell non-Hodgkin lymphoma","volume":"108","author":"Makita","year":"2017","journal-title":"Cancer Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2018.03.001","article-title":"The application of car-T cell therapy in hematological malignancies: Advantages and challenges","volume":"8","author":"Zhao","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"B60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/jha2.338","article-title":"Overview of approved car-T therapies, ongoing clinical trials, and its impact on clinical practice","volume":"3","author":"Sengsayadeth","year":"2022","journal-title":"eJHaem"},{"key":"B61","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12957-021-02486-x","article-title":"Overview of the pre-clinical and clinical studies about the use of car-T cell therapy of cancer combined with oncolytic viruses","volume":"20","author":"Zarezadeh Mehrabadi","year":"2022","journal-title":"World J Surg Oncol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor antigen escape from car T-cell therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discovery"},{"key":"B63","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"Car-T cell therapy: Current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01128","article-title":"Overcoming chimeric antigen receptor (Car) modified T-cell therapy limitations in multiple myeloma","volume":"11","author":"Garc\u00eda-Guerrero","year":"2020","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.756","article-title":"Cytokine release syndrome with chimeric antigen receptor T cell therapy","volume":"25","author":"Frey","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0041-7","article-title":"Car T cell-induced cytokine release syndrome is mediated by macrophages and abated by il-1 blockade","volume":"24","author":"Giavridis","year":"2018","journal-title":"Nat Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13287-020-02128-1","article-title":"Car T cells in solid tumors: Challenges and opportunities","volume":"12","author":"Marofi","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.841425","article-title":"Update for advance car-T therapy in solid tumors, clinical application in peritoneal carcinomatosis from colorectal cancer and future prospects","volume":"13","author":"Qian","year":"2022","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"nwab172","DOI":"10.1093\/nsr\/nwab172","article-title":"Scattered seeding of car T cells in solid tumors augments anticancer efficacy","volume":"9","author":"Li","year":"2021","journal-title":"Natl Sci Rev"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01702-9","article-title":"Gut microbiome correlates of response and toxicity following anti-Cd19 car T cell therapy","volume":"28","author":"Smith","year":"2022","journal-title":"Nat Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1163462","article-title":"Role of il-2 in cancer immunotherapy","volume":"5","author":"Jiang","year":"2016","journal-title":"Oncoimmunology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13045-021-01115-0","article-title":"T-Cell receptor-based therapy: An innovative therapeutic approach for solid tumors","volume":"14","author":"Tsimberidou","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem J"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00607","article-title":"Interactions between the gut microbiota and the host innate immune response against pathogens","volume":"10","author":"Cheng","year":"2019","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/nmo.12046","article-title":"Gut microbiota and gastrointestinal health: Current concepts and future directions","volume":"25","author":"Aziz","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4255","article-title":"Commensal bifidobacterium promotes antitumor immunity and facilitates anti-Pd-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"B77","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40164-019-0155-8","article-title":"Gut microbiome and car-T therapy","volume":"8","author":"Abid","year":"2019","journal-title":"Exp Hematol Oncol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.670286","article-title":"The potential role of the intestinal micromilieu and individual microbes in the immunobiology of chimeric antigen receptor T-cell therapy","volume":"12","author":"Schubert","year":"2021","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"8902","DOI":"10.3390\/ijms21238902","article-title":"New frontiers about the role of human microbiota in immunotherapy: The immune checkpoint inhibitors and car T-cell therapy era","volume":"21","author":"Innao","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-Pd-1 efficacy in metastatic melanoma patients","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by ctla-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"key":"B82","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-Pd-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.669150","article-title":"Modulation of gut microbiota to enhance effect of checkpoint inhibitor immunotherapy","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.756872","article-title":"Intestinal microbiome associated with immune-related adverse events for patients treated with anti-Pd-1 inhibitors, a real-world study","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.3095","article-title":"Gut microbiome to predict efficacy and immune-related toxicities in patients with advanced non-small cell lung cancer treated with anti-Pd-1\/Pd-L1 antibody-based immunotherapy","volume":"38","author":"Hakozaki","year":"2020","journal-title":"J Clin Oncol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v7.i4.405","article-title":"Immune checkpoint inhibitor-induced colitis: A comprehensive review","volume":"7","author":"Som","year":"2019","journal-title":"World J Clin cases"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.13661","article-title":"Modulation of gut mucosal microbiota as a mechanism of probiotics-based adjunctive therapy for ulcerative colitis","volume":"13","author":"Chen","year":"2020","journal-title":"Microb Biotechnol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"12506","DOI":"10.3390\/ijms222212506","article-title":"Therapeutic advances in gut microbiome modulation in patients with inflammatory bowel disease from pediatrics to adulthood","volume":"22","author":"Eindor-Abarbanel","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/506290a","article-title":"Policy: How to regulate faecal transplants","volume":"506","author":"Smith","year":"2014","journal-title":"Nature"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/all.14750","article-title":"Pros and cons: Is faecal microbiota transplantation a safe and efficient treatment option for gut dysbiosis","volume":"76","author":"Marrs","year":"2021","journal-title":"Allergy"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.653653","article-title":"Dietary management for faecal microbiota transplant: An international survey of clinical and research practice, knowledge and attitudes","volume":"8","author":"Clancy","year":"2021","journal-title":"Front Nutr"},{"key":"B92","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00394-017-1546-4","article-title":"Systematic review of the effects of the intestinal microbiota on selected nutrients and non-nutrients","volume":"57","author":"Shortt","year":"2018","journal-title":"Eur J Nutr"},{"key":"B93","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jnutbio.2015.08.013","article-title":"Nutritional modulation of gut microbiota - the impact on metabolic disease pathophysiology","volume":"28","author":"Ojeda","year":"2016","journal-title":"J Nutr Biochem"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.3390\/nu13072217","article-title":"Diet, microbiome, and cancer immunotherapy-a comprehensive review","volume":"13","author":"Szczyrek","year":"2021","journal-title":"Nutrients"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.3390\/nu13082795","article-title":"Effect of diet and dietary components on the composition of the gut microbiota","volume":"13","author":"Beam","year":"2021","journal-title":"Nutrients"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3390\/nu13051655","article-title":"Dietary fibre modulates the gut microbiota","volume":"13","author":"Cronin","year":"2021","journal-title":"Nutrients"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.3390\/nu12051348","article-title":"High intake of sugar and the balance between pro- and anti-inflammatory gut bacteria","volume":"12","author":"Satokari","year":"2020","journal-title":"Nutrients"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2019.00047","article-title":"The effects of vegetarian and vegan diets on gut microbiota","volume":"6","author":"Tomova","year":"2019","journal-title":"Front Nutr"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1039\/D0FO01483D","article-title":"Phytochemicals as modifiers of gut microbial communities","volume":"11","author":"Dingeo","year":"2020","journal-title":"Food Funct"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1177\/1535370218763760","article-title":"Carotenoid supplementation and retinoic acid in immunoglobulin a regulation of the gut microbiota dysbiosis","volume":"243","author":"Lyu","year":"2018","journal-title":"Exp Biol Med (Maywood)"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-021-00749-2","article-title":"Generation of systemic antitumour immunity Via the in situ modulation of the gut microbiome by an orally administered inulin gel","volume":"5","author":"Han","year":"2021","journal-title":"Nat BioMed Eng"},{"key":"B102","doi-asserted-by":"publisher","first-page":"376387","DOI":"10.1155\/2015\/376387","article-title":"Edible mushrooms: Improving human health and promoting quality life","volume":"2015","author":"Valverde","year":"2015","journal-title":"Int J Microbiol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115037","article-title":"Lentinula edodes-derived polysaccharide alters the spatial structure of gut microbiota in mice","volume":"10","author":"Xu","year":"2015","journal-title":"PloS One"},{"key":"B104","doi-asserted-by":"publisher","first-page":"108870","DOI":"10.1016\/j.foodres.2019.108870","article-title":"Structure characterization of soluble dietary fiber fractions from mushroom lentinula edodes (Berk.) pegler and the effects on fermentation and human gut microbiota in vitro","volume":"129","author":"Xue","year":"2020","journal-title":"Food Res Int"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232972","article-title":"Polysaccharides isolated from cordyceps sinensis contribute to the progression of Nash by modifying the gut microbiota in mice fed a high-fat diet","volume":"15","author":"Chen","year":"2020","journal-title":"PloS One"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1111\/1750-3841.15319","article-title":"Polysaccharide isolated from auricularia auricular-judae (Bull.) prevents dextran sulfate sodium-induced colitis in mice through modulating the composition of the gut microbiota","volume":"85","author":"Zhao","year":"2020","journal-title":"J Food Sci"},{"key":"B107","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ijbiomac.2019.11.047","article-title":"Intake of ganoderma lucidum polysaccharides reverses the disturbed gut microbiota and metabolism in type 2 diabetic rats","volume":"155","author":"Chen","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"104230","DOI":"10.1016\/j.jff.2020.104230","article-title":"Regulatory effects of a grifola frondosa extract rich in pseudobaptigenin and cyanidin-3-O-Xylosylrutinoside on glycolipid metabolism and the gut microbiota in high-fat diet-fed rats","volume":"75","author":"Deng","year":"2020","journal-title":"J Funct Foods"},{"key":"B109","doi-asserted-by":"publisher","first-page":"100578","DOI":"10.1016\/j.aqrep.2020.100578","article-title":"Dietary administration of pleurotus ostreatus polysaccharides (Pops) modulates the non-specific immune response and gut microbiota diversity of apostichopus japonicus","volume":"19","author":"Song","year":"2021","journal-title":"Aquacult Rep"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3390\/nu13031008","article-title":"Influence of short-term consumption of hericium erinaceus on serum biochemical markers and the changes of the gut microbiota: A pilot study","volume":"13","author":"Xie","year":"2021","journal-title":"Nutrients"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.12938\/bmfh.2020-018","article-title":"Polysaccharide from wild morels alters the spatial structure of gut microbiota and the production of short-chain fatty acids in mice","volume":"39","author":"Huo","year":"2020","journal-title":"Biosci Microbiota Food Health"},{"key":"B112","doi-asserted-by":"publisher","first-page":"104937","DOI":"10.1016\/j.phrs.2020.104937","article-title":"An integrated microbiome and metabolomic analysis identifies immunoenhancing features of ganoderma lucidum spores oil in mice","volume":"158","author":"Wu","year":"2020","journal-title":"Pharmacol Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1136\/gutjnl-2016-313271","article-title":"Prebiotic inulin-type fructans induce specific changes in the human gut microbiota","volume":"66","author":"Vandeputte","year":"2017","journal-title":"Gut"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1039\/d0fo02224a","article-title":"Yeast \u03b2-glucan, a potential prebiotic, showed a similar probiotic activity to inulin","volume":"11","author":"Wang","year":"2020","journal-title":"Food Funct"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201242841","article-title":"\u03b2-glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells","volume":"43","author":"Tian","year":"2013","journal-title":"Eur J Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12508","article-title":"Polysaccharide agaricus blazei murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion Via the toll-like receptor 2 pathway","volume":"146","author":"Liu","year":"2015","journal-title":"Immunology"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.02.058","article-title":"Alginate\/\u03ba-carrageenan oral microcapsules loaded with agaricus bisporus polysaccharides Mh751906 for natural killer cells mediated colon cancer immunotherapy","volume":"205","author":"El-Deeb","year":"2022","journal-title":"Int J Biol Macromolecules"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1615\/IntJMedMushrooms.v19.i4.50","article-title":"A king bolete, boletus edulis (Agaricomycetes), rna fraction stimulates proliferation and cytotoxicity of natural killer cells against myelogenous leukemia cells","volume":"19","author":"Lemieszek","year":"2017","journal-title":"Int J Med Mushrooms"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2019.09.179","article-title":"Lachnum polysaccharide suppresses S180 sarcoma by boosting anti-tumor immune responses and skewing tumor-associated macrophages toward M1 phenotype","volume":"144","author":"Zong","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.6b00932","article-title":"Immunomodulatory activity of polysaccharide-protein complex from the mushroom sclerotia of polyporus rhinocerus in murine macrophages","volume":"64","author":"Liu","year":"2016","journal-title":"J Agric Food Chem"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.4980","article-title":"Antagonism by ganoderma lucidum polysaccharides against the suppression by culture supernatants of B16f10 melanoma cells on macrophage","volume":"28","author":"Lu","year":"2014","journal-title":"Phytother Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-014-6027-6","article-title":"Activation of antitumor immune responses by ganoderma formosanum polysaccharides in tumor-bearing mice","volume":"98","author":"Wang","year":"2014","journal-title":"Appl Microbiol Biotechnol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2019.03.001","article-title":"Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China","volume":"163","author":"Dou","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.02.050","article-title":"Cordyceps militaris polysaccharide converts immunosuppressive macrophages into M1-like phenotype and activates T lymphocytes by inhibiting the pd-L1\/Pd-1 axis between tams and T lymphocytes","volume":"150","author":"Bi","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321031","article-title":"Ginseng polysaccharides alter the gut microbiota and Kynurenine\/Tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1\/Programmed cell death ligand 1 (Anti-Pd-1\/Pd-L1) immunotherapy","volume":"71","author":"Huang","year":"2022","journal-title":"Gut"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-012-1275-8","article-title":"Combining a peptide vaccine with oral ingestion of lentinula edodes mycelia extract enhances anti-tumor activity in B16 melanoma-bearing mice","volume":"61","author":"Tanaka","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1089\/109662003772519949","article-title":"Effect of maitake (Grifola frondosa) d-fraction on the activation of nk cells in cancer patients","volume":"6","author":"Kodama","year":"2003","journal-title":"J Med Food"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1081\/IMM-120022979","article-title":"Effects of ganopoly (a ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients","volume":"32","author":"Gao","year":"2003","journal-title":"Immunol Invest"},{"key":"B129","doi-asserted-by":"publisher","first-page":"809614","DOI":"10.1155\/2012\/809614","article-title":"Spore powder of ganoderma lucidum improves cancer-related fatigue in breast cancer patients undergoing endocrine therapy: A pilot clinical trial","volume":"2012","author":"Zhao","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcme.2015.11.004","article-title":"Enhancement of the Th1-phenotype immune system by the intake of oyster mushroom (Tamogitake) extract in a double-blind, placebo-controlled study","volume":"6","author":"Tanaka","year":"2016","journal-title":"J Tradit Complement Med"},{"key":"B131","first-page":"1","article-title":"Polysaccharide from lentinus edodes for integrative cancer treatment: Immunomodulatory effects on lymphocyte population","volume":"3","author":"Del Buono","year":"2016","journal-title":"WCRJ"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29421","article-title":"A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells for agaricus bisporus-induced prostate-specific antigen responses","volume":"121","author":"Twardowski","year":"2015","journal-title":"Cancer"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2021.11.017","article-title":"Medicinal mushrooms: Clinical perspective and challenges","volume":"27","author":"Panda","year":"2022","journal-title":"Drug Discovery Today"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-resistant e. coli bacteremia transmitted by fecal microbiota transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"New Engl J Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1007\/s40278-019-63893-8","article-title":"Serious aes linked with investigational faecal microbiota","volume":"1759","year":"2019","journal-title":"Reactions Weekly"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1038710\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T17:36:03Z","timestamp":1678296963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1038710\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":135,"alternative-id":["10.3389\/fonc.2023.1038710"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1038710","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]},"article-number":"1038710"}}